Terug
Dagbereik
€ 7,55
€ 7,82
52-Weeksbereik
€ 7,39
€ 16,79
Volume
9.748.379
50D / 200D Gem.
€ 9,98
/
€ 12,00
Vorige Slotkoers
€ 7,51
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -9,8 | 0,4 |
| P/B | 0,9 | 2,9 |
| ROE % | -9,2 | 3,7 |
| Net Margin % | -8,1 | 3,8 |
| Rev Growth 5Y % | -3,0 | 10,0 |
| D/E | 0,7 | 0,2 |
Belangrijkste Punten
Revenue declined -2,95% annually over 5 years
Earnings declined -174,52% over the past year
Generating 495,00M in free cash flow
PEG of 0,08 suggests growth is underpriced
Capital efficient — spends only 1,97% of revenue on capex
Groei
Revenue Growth (5Y)
-2,95%
Revenue (1Y)-3,41%
Earnings (1Y)-174,52%
FCF Growth (3Y)-17,29%
Kwaliteit
Return on Equity
-9,20%
ROIC-1,94%
Net Margin-8,09%
Op. Margin-3,76%
Veiligheid
Debt / Equity
0,71
Current Ratio1,78
Interest Coverage-1,45
Waardering
P/E Ratio
-9,76
P/B Ratio0,93
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3,41% | Revenue Growth (3Y) | -3,02% |
| Earnings Growth (1Y) | -174,52% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -2,95% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 6,55B | Net Income (TTM) | -530,20M |
| ROE | -9,20% | ROA | -4,50% |
| Gross Margin | 32,65% | Operating Margin | -3,76% |
| Net Margin | -8,09% | Free Cash Flow (TTM) | 495,00M |
| ROIC | -1,94% | FCF Growth (3Y) | -17,29% |
| Safety | |||
| Debt / Equity | 0,71 | Current Ratio | 1,78 |
| Interest Coverage | -1,45 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,76 | P/B Ratio | 0,93 |
| P/S Ratio | 0,79 | PEG Ratio | 0,08 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 5,18B | Enterprise Value | 8,76B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6,55B | 6,78B | 6,97B | 7,51B | 7,39B |
| Net Income | -530,20M | 711,50M | 321,10M | 686,50M | 572,60M |
| EPS (Diluted) | -0,78 | 1,04 | 0,47 | 1,01 | 0,85 |
| Gross Profit | 2,14B | 2,28B | 2,36B | 2,60B | 2,50B |
| Operating Income | -246,20M | 1,08B | 696,40M | 1,13B | 972,20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 11,79B | 12,11B | 12,97B | 13,46B | 13,90B |
| Total Liabilities | 6,23B | 6,16B | 7,72B | 8,61B | 9,70B |
| Shareholders' Equity | 5,57B | 5,96B | 5,25B | 4,86B | 4,20B |
| Total Debt | 3,95B | 4,06B | 5,54B | 6,29B | 7,02B |
| Cash & Equivalents | 365,40M | 261,90M | 262,90M | 372,90M | 301,70M |
| Current Assets | 2,45B | 2,15B | 2,38B | 2,66B | 2,48B |
| Current Liabilities | 1,38B | 2,01B | 1,48B | 1,66B | 1,45B |